The private equity rollup has arrived in full force at the intersection of RCM services and AI, and New Mountain Capital's assembly of Smarter Technologies represents the most ambitious bet yet that the future of revenue cycle belongs to platforms that can deliver both global operational scale and proprietary AI in a single contract. The combined entity — formed from Access Healthcare, Thoughtful AI, and SmarterDx — has raised $1.49B in total capital, serves more than 200 healthcare organizations across the U.S., and is now competing directly for full-outsourcing contracts that previously went exclusively to R1 RCM, Optum360, and Ensemble Health Partners. For billing directors and VPs of Revenue Cycle who are either current customers of one of the acquired companies or evaluating the market in 2026, the strategic implications of this rollup are material and require a structured analysis.
Executive Summary
- SmarterDx reports delivering an average of $2M in net new annual revenue per 10,000 patient discharges, rising to $2.5M following the Pieces Technologies acquisition and SmarterNotes launch, with a 5:1 ROI from Day 1 claimed across the combined CDI and documentation intelligence stack.
- Smarter Technologies has raised $1.49B in total capital from 11 investors including New Mountain Capital, Bessemer Venture Partners, Transformation Capital, Eir Partners, and Concord Health Partners, signaling institutional conviction in the AI-plus-services model that neither pure-tech nor pure-outsourcing vendors can currently replicate.
- The platform claims to automate up to 80% of revenue cycle tasks — including eligibility verification, documentation integrity, coding accuracy, claims processing, and denial management — without requiring health systems to replace existing EHR environments or retrain internal staff.
What makes this rollup structurally different from prior RCM consolidations is the deliberate sequencing of capability acquisition. New Mountain Capital did not simply buy a large BPO and bolt on a software license; it identified what its CEO described as "market leaders across the most important areas of agentic-AI, machine learning and clinical data, and large-scale automation" and combined them into a single commercial entity. Understanding each component's heritage — and the integration seams between them — is essential before any health system signs a multi-year agreement with Smarter Technologies or extends the scope of an existing relationship with one of its predecessor brands.
The Landscape: Rcm Market 2026
The revenue cycle management market has entered a phase of structural stress that favors consolidated, AI-augmented vendors over point-solution providers. Payer prior authorization denial rates continue to climb, with the AMA reporting that 94% of physicians cite prior authorization as delaying necessary patient care. CMS finalized the Interoperability and Prior Authorization Rule (CMS-0057-F) in January 2024, requiring most payers to implement electronic prior authorization APIs by January 1, 2027 — a mandate that will reduce administrative friction on the front end but will not eliminate the clinical documentation burden that drives CDI and coding complexity on the back end. At the same time, health system operating margins remain compressed, and administrative costs account for approximately 34.2% of total hospital expenditures according to a 2023 JAMA study — a figure that has not materially declined despite two decades of EHR adoption and process standardization.
Against this backdrop, health system CFOs and VPs of Revenue Cycle face a strategic choice between three operating models: build internal RCM capability and invest in point-solution AI tools, sign a full-outsourcing contract with an established player like R1 or Optum360, or adopt a hybrid model that pairs global BPO operations with modular, AI-native automation. Smarter Technologies is explicitly targeting the third lane. Its positioning as a "Services as Software" platform — borrowing the construct from enterprise SaaS but applying it to labor-intensive revenue cycle workflows — is designed to appeal to health systems that want cost certainty, AI capability, and operational flexibility without surrendering control of their revenue cycle strategy.
The AMA's 2024 Prior Authorization Physician Survey reports 94% of physicians cite prior authorization as delaying necessary patient care, creating upstream documentation and denial management pressure that cascades into CDI and coding workflows.
The competitive set in 2026 includes R1 RCM, which has historically dominated large health system outsourcing through long-term fee-for-service contracts; Optum360, which brings UnitedHealth Group's payer intelligence as a structural advantage; and Ensemble Health Partners, which has built strong mid-market health system relationships through a co-sourcing model. Smarter Technologies enters this field with a differentiated value proposition: the depth of a clinical AI platform (SmarterDx), the automation breadth of an agentic AI layer (Thoughtful AI), and the global operational scale of Access Healthcare — all under one commercial agreement.
How The Platform Works
The Smarter Technologies architecture rests on three distinct capability layers that map to the three acquired companies. The foundation is Access Healthcare, which provides the global BPO infrastructure — high-volume, low-cost operational execution across eligibility verification, claims processing, payment posting, and denial management. Access Healthcare's global operations platform is characterized by its leaders as offering "the lowest cost to serve, highest quality global operations platform at scale," and it is this component that allows Smarter Technologies to compete on total cost of ownership against offshore-heavy incumbents.
Layered on top of that operational foundation is Thoughtful AI, which contributes the agentic AI automation capability. Thoughtful AI developed AI agents and tools specifically focused on RCM workflows, providing organizations with complex medical billing specialties a comprehensive and flexible SaaS RCM solution. In practical terms, this means intelligent software agents that can execute multi-step revenue cycle processes — eligibility checks, claim status follow-up, denial routing, appeal letter generation — with human-in-the-loop oversight built into the workflow design. The platform claims to automate up to 80% of revenue cycle tasks without replacing existing systems, which is a critical selling point for health systems that have made significant EHR investments and cannot absorb a rip-and-replace technology transition.
The clinical intelligence layer is SmarterDx, which is now expanded through the acquisition of Pieces Technologies and the launch of SmarterNotes. SmarterDx uses a clinical ontology that understands tens of thousands of diagnoses and procedures to improve reimbursement accuracy and prevent coding errors. Its flagship use case is CDI optimization: transforming complex clinical data into fully attributable, actionable insights that enable more accurate documentation and coding at or near the point of care. The Pieces Intelligence Platform, now integrated as SmarterNotes, delivers AI-generated documentation and clinical summaries to assist physicians, nurses, and case managers within the EHR — and it is backed by NIH funding, which is a meaningful credentialing signal for hospital medical staff and CMOs who are skeptical of vendor-driven clinical AI claims.
SmarterNotes data shows 12M+ cases analyzed, 10% faster discharge summaries completed before discharge, and 69% to 76% fewer late nights spent on pajama-time documentation.
The integration between these three layers is managed through what Smarter Technologies describes as a modular, EHR-agnostic architecture. Providers do not need to change anything in their current technology environments. This modularity is a double-edged sword: it reduces initial implementation friction but also means health systems can, in theory, select individual modules rather than committing to the full platform — a buyer behavior that creates revenue concentration risk for the vendor and negotiating leverage for the customer.
Where It Delivers Value
The clearest and most defensible value proposition in the Smarter Technologies portfolio sits in CDI and revenue integrity, anchored by SmarterDx. The $2M in net new annual revenue per 10,000 patient discharges — rising to $2.5M with the Pieces Technologies integration — is a specific, auditable metric that billing directors can pressure-test against their own current CDI yield. For a 300-bed community hospital with 15,000 discharges annually, that translates to $3.75M in net new annual revenue at the $2.5M per 10,000 benchmark. For a 600-bed academic medical center with 35,000 discharges, the potential impact exceeds $8.75M annually. These are not trivial numbers in a margin environment where health systems are fighting for every basis point.
Note that SmarterDx's revenue recovery benchmarks are self-reported and based on retrospective chart analysis identifying undercaptured diagnoses, CC/MCC assignments, and HCC gaps. Before accepting these figures at face value, procurement teams should request a blinded pilot on a defined patient cohort — minimum 1,000 discharges — with results audited by an independent CDI consultant or internal compliance staff against the facility's actual remittance data. Vendor-reported CDI lift figures regularly overstate sustainable yield when applied to facilities with already-mature CDI programs; the $2.5M per 10,000 benchmark is most credible for organizations with query rates below 25% or CC/MCC capture rates below 50%.
SmarterDx reports identifying new CC/MCC opportunities in 36% of analyzed encounters, a capture rate that directly impacts DRG weight and case mix index. This figure should be validated against your facility's current CC/MCC capture rate and payer mix before projecting revenue impact, as the incremental lift for facilities with mature CDI programs will be materially lower.
The agentic AI layer from Thoughtful AI delivers measurable value in high-volume, rules-based workflows: eligibility verification, claim status follow-up, ERA posting, and denial categorization. These are tasks that traditionally consume large volumes of FTE hours at relatively low complexity — exactly the workflow profile where AI agents can achieve high automation rates without sacrificing accuracy. The platform's intelligent analytics identify patterns, detect inefficiencies, and support faster decision-making across revenue cycle workflows, enabling earlier intervention before operational issues escalate into financial problems.
Access Healthcare's contribution is less about AI innovation and more about cost arbitrage and operational depth. Global BPO operations provide the human escalation layer when AI agents encounter exceptions, and they provide the capacity buffer that health systems need during volume surges, payer contract transitions, or technology implementations. The combination of AI automation with skilled human operational support is precisely what the market has been asking for: not a fully autonomous AI that removes human judgment from consequential clinical and financial decisions, but a system that directs human effort to where it creates the most value.
When evaluating Smarter Technologies, request separate performance SLAs for each of the three capability layers — CDI accuracy, agentic automation rates, and offshore operational metrics — so you can hold each component accountable on its own terms.
Competitive Positioning
Smarter Technologies competes in a market where the dominant players have established deep contractual relationships, proprietary payer data, and multi-year implementation track records. R1 RCM has historically won large health system outsourcing contracts through a combination of technology investment and operational scale. Optum360 leverages its position within the UnitedHealth ecosystem to offer payer-side intelligence that independent RCM vendors cannot replicate. Ensemble Health Partners has carved out strong positioning in the mid-market through a co-sourcing model that preserves more health system control than full outsourcing.
Smarter Technologies' competitive differentiation is the "Services as Software" construct — a positioning that attempts to escape the binary choice between pure outsourcing (high switching costs, loss of strategic control) and pure technology licensing (implementation burden on the health system, dependency on internal operational capability). The modular architecture allows a health system to start with SmarterDx CDI optimization, layer in Thoughtful AI automation for specific workflow nodes, and then expand to broader Access Healthcare operational support — or any other sequencing that matches its current capability gaps.
| Vendor | Model | AI Depth | Global Operations | CDI / Revenue Integrity | Full Outsourcing |
|---|---|---|---|---|---|
| Smarter Technologies | Services as Software | Proprietary (Agentic + Clinical) | Yes (Access Healthcare) | SmarterDx + SmarterNotes | Yes |
| R1 RCM | Full Outsourcing + Tech | Platform AI | Yes | Limited proprietary CDI | Yes |
| Optum360 | Full Outsourcing | Payer-informed AI | Yes | Moderate | Yes |
| Ensemble Health Partners | Co-sourcing | Moderate | Limited | Moderate | Partial |
Optum360's payer-side data advantage is structural and cannot be replicated by any independent RCM vendor — health systems with high UnitedHealthcare payer mix should weigh this factor carefully in competitive evaluations. Note also that UnitedHealth Group's acquisition of Change Healthcare creates additional data integration advantages for Optum360 that are subject to ongoing DOJ antitrust scrutiny; health systems should monitor regulatory developments that could affect this competitive dynamic.
The "Services as Software" label also positions Smarter Technologies against the venture-backed pure-play AI vendors that have flooded the RCM market since 2022. Those vendors typically offer point-solution automation for specific workflow steps — prior auth, denial prediction, coding suggestions — but lack the operational backbone to deliver guaranteed financial outcomes. Smarter Technologies' combination of AI automation and global human operations allows it to offer outcome-based pricing conversations that pure-tech vendors cannot credibly have.
Pricing And Roi Analysis
Smarter Technologies prices its platform through two primary mechanisms: a percentage-of-net-revenue model for the full-service operational layer (consistent with industry standard RCM outsourcing contracts), and a technology licensing layer for health systems that want modular access to specific AI capabilities without full operational outsourcing. This dual pricing structure is strategically important because it allows Smarter Technologies to compete for both the large health system full-outsourcing RFP and the more targeted technology procurement process.
Percentage-of-net-collections pricing for full-service RCM outsourcing typically ranges from 3% to 8% of net collections depending on facility size, payer mix complexity, and scope of services — with larger health systems commanding rates at the lower end of that range. Health systems evaluating Smarter Technologies' full-platform pricing should benchmark against this industry range and require itemized pricing for each capability layer to understand what they are paying for operational services versus AI licensing versus CDI analytics.
For health systems evaluating the full platform, the financial case centers on total cost of ownership relative to the incumbent model. The relevant comparison is not Smarter Technologies' fee versus the cost of an internal RCM team — it is Smarter Technologies' combined fee against the aggregate cost of current outsourcing contracts, internal FTE costs, point-solution technology licenses, CDI vendor fees, and unrealized revenue from documentation gaps. When modeled on a 15,000-discharge community hospital using the $2.5M SmarterNotes revenue recovery benchmark and a conservative 20% automation rate reduction in operational FTE costs, the financial case is compelling in year one.
| Facility Size | Annual Discharges | CDI Revenue Recovery (at $2.5M/10K) | Automation FTE Savings Potential | Combined Year 1 Value |
|---|---|---|---|---|
| Community Hospital | 10,000 | $2.5M | Varies by baseline | Additive |
| Mid-Size Health System | 20,000 | $5.0M | Significant | Strong |
| Academic Medical Center | 35,000 | $8.75M | High | Very Strong |
Percentage-of-net-revenue pricing structures create misaligned incentives during payer contract negotiations — ensure your contract specifies whether the revenue base is gross charges, allowed amounts, or net collections, and define how payer contract changes affect vendor compensation. Industry standard is percentage of net collections; percentage of gross charges is a red flag that inflates vendor compensation independent of actual performance.
The ROI case for the SmarterDx module is the most immediately verifiable. The 5:1 ROI from Day 1 claim is specific and testable: a health system can audit its current CDI query rate, CC/MCC capture rate, and case mix index trend, then pilot SmarterDx on a defined patient population and measure the yield difference. This is the engagement motion that Smarter Technologies' sales team should be proposing, and that procurement teams should be demanding before any enterprise commitment.
The 7 Powers Lens: Smarter Technologies Strategic Durability
Hamilton Helmer's 7 Powers framework is the most useful analytical lens for RCM buyers evaluating platform vendors precisely because it separates marketing narrative from durable competitive advantage. In a market where every vendor claims AI leadership, the 7 Powers analysis reveals which advantages are structural and self-reinforcing versus which are temporary and replicable. For a health system signing a five-to-seven year outsourcing agreement, understanding the strategic durability of its vendor is not an academic exercise — it determines whether the vendor will still be innovating and investing in year four or harvesting margin on a stale platform.
| Power | Strength | Assessment |
|---|---|---|
| Scale Economies | Moderate | Access Healthcare's global operations create meaningful per-unit cost advantages that increase with volume, but offshore BPO scale is replicable by sufficiently capitalized competitors including R1 and Optum360. |
| Network Economies | Emerging | SmarterDx's clinical ontology improves as more cases are analyzed (12M+ and growing); payer policy and denial pattern data compounds across the client base, creating a data network effect that strengthens over time. |
| Counter-Positioning | Strong | The Services as Software model — combining proprietary AI with global operations under outcome-based pricing — is structurally difficult for pure-tech vendors to replicate without building or acquiring BPO capability, and difficult for traditional BPOs to replicate without deep AI investment. |
| Switching Costs | Strong | Multi-layer platform adoption (CDI + agentic automation + global operations) creates compounding switching costs; replacing all three simultaneously is operationally prohibitive for most health systems. |
| Branding | Weak | Smarter Technologies is a newly formed brand; Access Healthcare, SmarterDx, and Thoughtful AI carry individual market recognition, but the unified brand has not yet established the trust premium of R1 or Optum in large health system procurement. |
| Cornered Resource | Moderate | The Pieces Technologies acquisition brings NIH-backed clinical AI and the proprietary physician reasoning model behind SmarterNotes — a resource that required years and external research funding to develop and is not easily replicated. |
| Process Power | Moderate | The integrated workflow between clinical documentation AI, agentic automation, and human operations creates a compounding process advantage, but the integration is early-stage and the process advantage will not fully materialize until the platform achieves deeper cross-layer data sharing. |
Counter-Positioning as the Dominant Power
Counter-positioning is Smarter Technologies' most durable strategic advantage and the one that its leadership appears to have deliberately engineered through the rollup structure. The Services as Software model occupies a position that incumbent RCM BPOs cannot easily attack without cannibalizing their existing revenue model, and that pure-tech AI vendors cannot easily attack without building or acquiring the operational infrastructure that makes outcome-based commitments credible. R1 RCM's existing contract base is structured around operational FTE deployment; shifting to a model that aggressively automates those FTEs away would require R1 to simultaneously restructure its cost base and reprice its existing contracts. That is a wrenching internal transition that large organizations historically delay until forced. Smarter Technologies has no such legacy constraint.
Biggest Strategic Vulnerability: Integration Execution Risk
The most significant strategic vulnerability is the one that all PE rollups face: the gap between the acquisition announcement and the actual integration of systems, data, and go-to-market motion. Access Healthcare, Thoughtful AI, and SmarterDx were independent companies with separate engineering teams, separate client contracts, separate operational methodologies, and separate cultures. The clinical ontology in SmarterDx needs to inform the agentic AI routing in Thoughtful AI's platform, which needs to connect to the workflow queues managed by Access Healthcare's global operations teams. Each of those integration points is a potential failure node. Health systems that signed contracts with any of the three predecessor companies under the assumption of a specific technology roadmap or support model should formally request updated integration timelines, API documentation, and contractual protections before the Q4 2026 renewal cycle.
Switching Cost Reality for Buyers
For health systems already using one of the three predecessor platforms, the switching cost analysis is asymmetric. If you are using SmarterDx for CDI and your CDI team has calibrated its query workflows to the platform's outputs, replacing it requires retraining clinical documentation specialists, recalibrating physician query template libraries, and absorbing a productivity trough during transition — typically 60 to 90 days of degraded CDI yield. If you have also layered in Thoughtful AI automation for eligibility and denial workflows, your IT team has built integration points to your EHR and clearinghouse that would need to be rebuilt for any replacement platform. The moment a health system adopts two of the three Smarter Technologies layers, the practical switching cost approaches the level of a full EHR migration in terms of operational disruption. This is architecturally intentional, and buyers should negotiate accordingly before they reach that level of platform dependence.
Implementation Experience
Early implementation feedback on the combined Smarter Technologies platform reflects the pattern common to first-generation rollup integrations: strong component performance, variable cross-platform coordination. Health systems report that SmarterDx's CDI module deploys rapidly and generates measurable results within 60 to 90 days of go-live, consistent with its 5:1 ROI from Day 1 positioning. The Thoughtful AI agentic automation layer requires more configuration